Crispr Therapeutics Ag (CRSP)

Revenue

$25.17M

TTM · Period ending: · USD

CRSP logo

CRSP Revenue

Latest reported$25.17M
CRSP TTM Revenue ($247.00K → $25.17M)
High-resolution chart · PNG

CRSP revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
25,172,000
13,392,000
4,103,000
3,510,000
37,646,000
37,359,000
36,984,000
36,623,000
201,623,000
201,021,000
270,504,000
370,000,000
170,006,000
170,100,000
100,258,000
436,000
13,329,000
13,564,000
913,608,000
913,632,000
901,103,000
900,922,000
764,000
719,000
77,365,000
289,145,000
289,419,000
289,590,000
212,689,000
1,324,000
2,094,000
3,124,000
35,334,000
37,158,000
39,652,000
40,997,000
11,016,000
10,178,000
7,391,000
5,164,000
3,067,000
1,518,000
723,000
247,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.